Novartis AG (NVS) Q2 2023 Earnings Call Transcript
Novartis AG (NYSE: NVS) Q2 2023 earnings call dated Jul. 18, 2023 Corporate Participants: Samir Shah — Global Head, Investor Relations Vasant (Vas) Narasimhan — Chief Executive Officer Harry…
10 articles, transcripts, and reports
Novartis AG (NYSE: NVS) Q2 2023 earnings call dated Jul. 18, 2023 Corporate Participants: Samir Shah — Global Head, Investor Relations Vasant (Vas) Narasimhan — Chief Executive Officer Harry…
Novartis AG (NYSE:NVS) Q1 2023 Earnings Call dated Apr. 25, 2023. Corporate Participants: Samir Shah — Global Head of Investor Relations Vasant Narasimhan — Chief Executive Officer Harry Kirsch — Chief…
Novartis AG (NYSE: NVS) Q4 2022 earnings call dated Feb. 01, 2023 Corporate Participants: Samir Shah — Global Head of Investor Relations Vas Narasimhan — Chief Executive Officer Harry…
Novartis AG (NYSE: NVS) Q3 2022 earnings call dated Oct. 25, 2022 Corporate Participants: Samir Shah — Global Head of Investor Relations Vasant Narasimhan — Chief Executive Officer Harry…
Novartis AG (NYSE: NVS) Q2 2022 earnings call dated Jul. 19, 2022 Corporate Participants: Samir Shah — Global Head of Investor Relations Vasant (Vas) Narasimhan — Chief Executive Officer…
Novartis AG (NYSE: NVS) Q2 2021 earnings call dated Jul. 21, 2021 Corporate Participants: Samir Shah — Global Head of Investor Relations Vasant Narasimhan —…
Novartis International AG (NYSE: NVS) Q4 2020 earnings call dated Jan. 26, 2021 Corporate Participants: Samir Shah — Global Head, Investor Relations and Global Finance Vas Narasimhan — Chief…
Novartis International AG (NYSE: NVS) Q2 2020 earnings call dated Jul. 21, 2020 Corporate Participants: Samir Shah — Global Head of Investor Relations Vasant Narasimhan — Chief Executive Officer…
Novartis International AG (NVS) Q1 2020 earnings call dated Apr. 28, 2020 Corporate Participants: Samir Shah — Global Head of Investor Relations Vasant Narasimhan — Chief Executive Officer Marie-France…
Nearly a year after laying out its transformation strategy, with focus on demerging underperforming business units, Novartis (NYSE: NVS) Tuesday said it completed the spin-off…